Fairvalue-Calculator Fairvalue-Calculator
EN DE

Revivegen Co (7578) Fair Value & Analysis

Industrials · TW · Market cap 1.8B TWD

Price30.95 TWD
Fair Value7.91 TWD
Upside-74.4%
Quality80/100
Evidence: Medium Range 5.54 TWD – 10.28 TWD

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Revivegen Co (7578) currently trades at 30.95 TWD, while our model-based Fair Value estimate is 7.91 TWD — implying the stock looks roughly 74.4% overvalued today. We read business quality at 80/100 (high quality), in the Industrials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).

About the company

Revivegen Co., Ltd. engages in the industrial waste treatment business in Taiwan. It is involved in the waste solvent physical treatment and thermal treatment activities; and provision of semiconductor cleaning agent, chip cleaning agent, paint and coating additives, and lithium battery auxiliary materials. Revivegen Co., Ltd. was founded in 2010 and is headquartered in Tainan City, Taiwan.

Open the full interactive analysis →

Similar stocks

Waste Management, Inc (WM) -42% UWS (UWS) -37% Republic Services, Inc (RSG) -42% Waste Connections, Inc (WCN) -44% Veolia Environnement SA (VEOEF) -13% Clean Harbors, Inc (CLH) -46%

Frequently asked questions

Is Revivegen Co (7578) undervalued?
As of Jun 24, 2026, our model estimates a fair value of 7.91 TWD versus a price of 30.95 TWD — about −74% (overvalued). Model-based estimate, not financial advice.
What is the fair value of 7578?
Our 21-model fair value for Revivegen Co is 7.91 TWD (as of Jun 24, 2026), built from audited fundamentals. The current price is 30.95 TWD.
What is the quality score of 7578?
Revivegen Co has a Quality Score of 80/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.